secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHAMPIONS ONCOLOGY, INC. (CSBR)
CIK:        0000771856
Form:       8-K
Filed at:   2026-10-16T16:15:14+00:00
Accession:  0001628280-26-066087
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4.1-flash:cloud@v2

Champions Oncology holders re-elect 7 directors, ratify EisnerAmper, approve 2026 Equity Incentive Plan
--------------------------------------------------------------------------------

- All seven director nominees elected at the Oct 14, 2026 annual meeting; Brian Alexander (8,241,264 for) and Scott Tobin (8,230,372) drew the least opposition.
- David Sidransky received 7,154,225 for vs 1,088,685 withheld, the largest dissent; Robert Brainin got 7,904,120 for / 338,790 withheld.
- EisnerAmper LLP ratified as independent auditor for fiscal year ending April 30, 2027, by 8,702,771 for to 1,845 against.
- 2026 Equity Incentive Plan approved 6,401,638 for / 754,480 against (~10.5% opposition) with 1,086,792 abstentions.
- Say-on-pay approved 7,130,832 for vs 25,242 against; holders favored annual advisory votes (7,198,608 for 1 year), and the company will hold them yearly.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/771856/000162828026066087/0001628280-26-066087-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/771856/000162828026066087/csbr-20261014.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-066087

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer